Skip to main content

Table 2 Baseline characteristics of the participants according to SUA quartiles

From: Assessment of the relationship between serum uric acid and glucose levels in healthy, prediabetic and diabetic individuals

 

Q1 (≤ 249 µmol/L)

Q2 (250–321 µmol/L)

Q3 (322–387 µmol/L)

Q4 (> 387 µmol/L)

p-values for trend

N

77

80

79

74

–

Sex, m/f

40/37

53/27

60/19

62/12

–

Age, year

43.1 ± 12.6

42.4 ± 18.3

36.5 ± 15.0

36.2 ± 17.0

0.047

BMI, kg/m2

24.9 ± 4.8

25.6 ± 3.5

25.2 ± 3.6

25.8 ± 3.7

0.046

SUA, µmol/L

204.7 ± 37.0

292.1 ± 20.6

355.7 ± 18.6

477.1 ± 83.7

0.000

TG, mg/dL

170.9 ± 97.3

237.3 ± 167.9

175.8 ± 98.3

172.7 ± 86.6

0.028

TC, mg/dL

202.5 ± 69.1

202.0 ± 78.2

212.3 ± 96.2

212.1 ± 88.8

0.047

HDL, mg/dL

32.3 ± 12.6

36.7 ± 18.9

34.6 ± 15.2

36.8 ± 14.5

0.538

Albumin, g/dL

51.8 ± 18.1

45.8 ± 10.5

46.4 ± 10.1

47.6 ± 11.4

0.090

Total protein, g/dL

74.6 ± 27.6

78.6 ± 26.5

78.1 ± 18.9

84.7 ± 31.9

0.308

Glucose, mg/dL

177.6 ± 88.2

141.5 ± 72.0

139.9 ± 76.5

128.6 ± 65.1

0.008

MetS (%)

37.8

32.7

20.8

23.8

0.000a

  1. Values are presented as mean ± SD
  2. MetS metabolic syndrome
  3. p-values are obtained from one-way ANOVA
  4. ap-value is obtained from Chi square test when the percentages of MetS are compared among the groups